Evolus Inc (EOLS) stock is lower by 35.09% over the past week and gets a Bearish rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.
Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.
InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.
The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.
What's Happening With EOLS Stock Today?
Evolus Inc (EOLS) stock is down -10.83% while the S&P 500 has risen 0.57% as of 11:03 AM on Wednesday, Jul 8. EOLS is lower by -$0.42 from the previous closing price of $3.86 on volume of 909,109 shares. Over the past year the S&P 500 is up 6.30% while EOLS is lower by -77.07%. EOLS lost -$3.41 per share in the over the last 12 months.
To see the top 5 stocks in the Drug Manufacturers - Specialty & Generic industry click here.
More About Evolus Inc
Evolus Inc is engaged in providing physicians and their patients with expanded choices in medical aesthetic treatments and procedures. Its product candidate is an injectable formulation of a 900 kDa Botulinum toxin Type A complex. It has also completed the development program for DWP-450 for the treatment of moderate to severe glabellar lines.
